The Trump administration is preparing measures that could speed Food and Drug Administration authorization for vaping products and nicotine pouches, The Wall Street Journal reported, citing people familiar with the matter. The FDA is expected in coming days to revisit its 2021 requirements for new tobacco applications, potentially simplifying scientific studies and shortening review times, although Reuters could not independently verify the report and the agency did not immediately comment. The changes could benefit manufacturers seeking authorization for smoke-free nicotine products. Last month, the FDA allowed the marketing of three new JUUL2 e-cigarette products. A Department of Health and Human Services spokeswoman said the administration aims to keep nicotine away from children, remove counterfeit vaping products from the streets and provide safer alternatives for adults seeking to quit cigarettes. During U.S. President Donald Trump's first term, his administration moved to pull flavored e-cigarettes from retail shelves over concerns about youth nicotine addiction.